Charles Glasier
Concepts (492)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 61 | 2026 | 1583 | 2.480 |
Why?
| | Brain | 28 | 2023 | 1350 | 1.750 |
Why?
| | Tomography, X-Ray Computed | 31 | 2021 | 1180 | 1.360 |
Why?
| | Brain Diseases | 9 | 2013 | 85 | 0.870 |
Why?
| | Radiation Dosage | 5 | 2021 | 160 | 0.840 |
Why?
| | Optic Nerve | 10 | 2024 | 46 | 0.820 |
Why?
| | Child | 66 | 2026 | 7379 | 0.800 |
Why?
| | Infant, Newborn | 42 | 2025 | 2913 | 0.710 |
Why?
| | Child, Preschool | 52 | 2023 | 4162 | 0.700 |
Why?
| | Eye Abnormalities | 3 | 2014 | 25 | 0.680 |
Why?
| | Infant | 49 | 2023 | 3805 | 0.680 |
Why?
| | Diffusion Tensor Imaging | 9 | 2023 | 104 | 0.650 |
Why?
| | Magnetic Resonance Angiography | 6 | 2015 | 72 | 0.580 |
Why?
| | Humans | 122 | 2026 | 53230 | 0.540 |
Why?
| | Sturge-Weber Syndrome | 1 | 2017 | 13 | 0.530 |
Why?
| | Hypopituitarism | 2 | 2014 | 16 | 0.520 |
Why?
| | Anxiety | 3 | 2026 | 321 | 0.520 |
Why?
| | Pituitary Gland | 2 | 2014 | 87 | 0.490 |
Why?
| | Brain Injuries | 5 | 2023 | 160 | 0.480 |
Why?
| | Male | 76 | 2026 | 27435 | 0.480 |
Why?
| | Ultrasonography | 18 | 1992 | 426 | 0.470 |
Why?
| | Female | 74 | 2026 | 28782 | 0.470 |
Why?
| | Hematoma, Epidural, Cranial | 1 | 2015 | 6 | 0.470 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2015 | 18 | 0.460 |
Why?
| | Phlebography | 1 | 2015 | 55 | 0.460 |
Why?
| | Intracranial Hemorrhages | 1 | 2015 | 44 | 0.450 |
Why?
| | Neuroimaging | 1 | 2015 | 95 | 0.440 |
Why?
| | Spasms, Infantile | 2 | 2014 | 31 | 0.440 |
Why?
| | Aicardi Syndrome | 1 | 2014 | 3 | 0.430 |
Why?
| | Ketones | 1 | 2014 | 10 | 0.430 |
Why?
| | Pregnancy Complications | 3 | 2026 | 406 | 0.420 |
Why?
| | Optic Disk | 3 | 2002 | 23 | 0.410 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2026 | 214 | 0.380 |
Why?
| | Spinal Dysraphism | 1 | 2011 | 39 | 0.350 |
Why?
| | Attention | 1 | 2011 | 169 | 0.340 |
Why?
| | Diffusion Magnetic Resonance Imaging | 4 | 2022 | 133 | 0.340 |
Why?
| | Depression | 3 | 2026 | 621 | 0.310 |
Why?
| | Adolescent | 36 | 2017 | 6907 | 0.310 |
Why?
| | Thiopental | 2 | 2001 | 3 | 0.290 |
Why?
| | Conscious Sedation | 2 | 2001 | 19 | 0.290 |
Why?
| | Demyelinating Diseases | 1 | 2008 | 8 | 0.280 |
Why?
| | Eye Diseases | 3 | 2001 | 36 | 0.280 |
Why?
| | Cerebral Hemorrhage | 4 | 2014 | 102 | 0.260 |
Why?
| | Neurodegenerative Diseases | 1 | 2008 | 81 | 0.260 |
Why?
| | Diagnosis, Differential | 10 | 2015 | 1038 | 0.260 |
Why?
| | Cerebrospinal Fluid Shunts | 5 | 2015 | 25 | 0.250 |
Why?
| | Optic Nerve Diseases | 2 | 2008 | 21 | 0.250 |
Why?
| | Cerebral Ventricles | 5 | 2015 | 27 | 0.250 |
Why?
| | Ocular Motility Disorders | 2 | 2007 | 16 | 0.250 |
Why?
| | Brain Edema | 4 | 2012 | 40 | 0.240 |
Why?
| | Child Abuse | 3 | 2023 | 145 | 0.240 |
Why?
| | Mothers | 4 | 2023 | 269 | 0.240 |
Why?
| | Osteomyelitis | 8 | 1996 | 134 | 0.230 |
Why?
| | Pregnancy | 9 | 2026 | 2608 | 0.220 |
Why?
| | Cerebral Cortex | 1 | 2026 | 194 | 0.220 |
Why?
| | Intracranial Aneurysm | 2 | 2011 | 47 | 0.220 |
Why?
| | Amygdala | 1 | 2025 | 35 | 0.220 |
Why?
| | Brain Mapping | 4 | 2021 | 223 | 0.210 |
Why?
| | Visual Pathways | 2 | 2002 | 12 | 0.210 |
Why?
| | Wounds and Injuries | 2 | 2017 | 301 | 0.200 |
Why?
| | Sodium, Dietary | 1 | 2023 | 24 | 0.200 |
Why?
| | Cerebellum | 2 | 2007 | 121 | 0.200 |
Why?
| | Strabismus | 2 | 2008 | 14 | 0.200 |
Why?
| | Hydrocephalus | 4 | 2015 | 46 | 0.190 |
Why?
| | Cognition | 3 | 2022 | 346 | 0.190 |
Why?
| | Craniocerebral Trauma | 1 | 2023 | 63 | 0.190 |
Why?
| | Spinal Cord | 2 | 1995 | 130 | 0.180 |
Why?
| | Trauma Centers | 3 | 2018 | 210 | 0.180 |
Why?
| | Visual Cortex | 1 | 2002 | 9 | 0.180 |
Why?
| | Blindness, Cortical | 1 | 2002 | 3 | 0.180 |
Why?
| | Arnold-Chiari Malformation | 2 | 2011 | 22 | 0.180 |
Why?
| | Cysts | 3 | 1995 | 53 | 0.180 |
Why?
| | Depressive Disorder, Major | 1 | 2023 | 149 | 0.180 |
Why?
| | Meningomyelocele | 3 | 2011 | 27 | 0.180 |
Why?
| | Nervous System Malformations | 1 | 2001 | 17 | 0.180 |
Why?
| | Choroid Plexus | 2 | 1993 | 8 | 0.180 |
Why?
| | Retrospective Studies | 11 | 2023 | 6819 | 0.170 |
Why?
| | Hypnotics and Sedatives | 1 | 2001 | 74 | 0.170 |
Why?
| | Meningitis, Haemophilus | 1 | 2021 | 7 | 0.170 |
Why?
| | Meningeal Neoplasms | 2 | 2009 | 52 | 0.170 |
Why?
| | Vasospasm, Intracranial | 1 | 2021 | 14 | 0.170 |
Why?
| | Abnormalities, Multiple | 4 | 2024 | 166 | 0.170 |
Why?
| | Arteriovenous Malformations | 1 | 2001 | 75 | 0.160 |
Why?
| | Follow-Up Studies | 12 | 2013 | 2318 | 0.160 |
Why?
| | Prospective Studies | 12 | 2025 | 2411 | 0.160 |
Why?
| | Sensitivity and Specificity | 7 | 2015 | 867 | 0.160 |
Why?
| | Diagnostic Imaging | 3 | 2001 | 176 | 0.160 |
Why?
| | Orbital Neoplasms | 3 | 2001 | 29 | 0.150 |
Why?
| | Abscess | 4 | 1992 | 43 | 0.150 |
Why?
| | Vestibulocochlear Nerve | 1 | 1999 | 4 | 0.150 |
Why?
| | Lumbar Vertebrae | 2 | 2010 | 101 | 0.150 |
Why?
| | Siderosis | 1 | 1999 | 3 | 0.150 |
Why?
| | Adult | 22 | 2026 | 14534 | 0.150 |
Why?
| | Agenesis of Corpus Callosum | 2 | 1995 | 11 | 0.140 |
Why?
| | Retina | 2 | 1996 | 76 | 0.140 |
Why?
| | Cross-Sectional Studies | 4 | 2017 | 1723 | 0.140 |
Why?
| | Musculoskeletal Abnormalities | 1 | 1998 | 14 | 0.140 |
Why?
| | Heart Defects, Congenital | 2 | 2015 | 625 | 0.140 |
Why?
| | Kyphosis | 1 | 1998 | 17 | 0.140 |
Why?
| | Thoracic Vertebrae | 1 | 1998 | 38 | 0.140 |
Why?
| | Hypernatremia | 1 | 1997 | 4 | 0.140 |
Why?
| | Sepsis | 1 | 2021 | 240 | 0.140 |
Why?
| | Meninges | 1 | 2017 | 13 | 0.130 |
Why?
| | Dehydration | 1 | 1997 | 26 | 0.130 |
Why?
| | Soft Tissue Neoplasms | 3 | 1989 | 62 | 0.130 |
Why?
| | Anisotropy | 4 | 2022 | 62 | 0.130 |
Why?
| | Cesarean Section | 1 | 2018 | 158 | 0.130 |
Why?
| | Blindness | 2 | 1996 | 33 | 0.130 |
Why?
| | Developmental Disabilities | 2 | 2013 | 127 | 0.130 |
Why?
| | Longitudinal Studies | 3 | 2026 | 774 | 0.130 |
Why?
| | Quadriplegia | 1 | 1996 | 8 | 0.130 |
Why?
| | Neurofibromatosis 2 | 1 | 1996 | 8 | 0.130 |
Why?
| | Registries | 2 | 2017 | 652 | 0.120 |
Why?
| | Brain Neoplasms | 6 | 2008 | 319 | 0.120 |
Why?
| | Rest | 1 | 2016 | 60 | 0.120 |
Why?
| | Atlanto-Axial Joint | 1 | 1996 | 8 | 0.120 |
Why?
| | Prefrontal Cortex | 1 | 2016 | 85 | 0.120 |
Why?
| | Adenoidectomy | 1 | 1996 | 36 | 0.120 |
Why?
| | Gestational Age | 1 | 2017 | 394 | 0.120 |
Why?
| | Infant, Newborn, Diseases | 1 | 2016 | 56 | 0.120 |
Why?
| | Deafness | 1 | 1996 | 37 | 0.120 |
Why?
| | Cervical Vertebrae | 1 | 1996 | 64 | 0.120 |
Why?
| | Cerebral Ventriculography | 1 | 2015 | 3 | 0.120 |
Why?
| | Dominance, Cerebral | 1 | 1995 | 26 | 0.120 |
Why?
| | False Positive Reactions | 1 | 2015 | 66 | 0.120 |
Why?
| | Spinal Nerve Roots | 3 | 2010 | 14 | 0.110 |
Why?
| | Pseudotumor Cerebri | 1 | 1995 | 24 | 0.110 |
Why?
| | Papilledema | 1 | 1995 | 28 | 0.110 |
Why?
| | Orbital Diseases | 2 | 1992 | 14 | 0.110 |
Why?
| | Reproducibility of Results | 2 | 2015 | 1219 | 0.110 |
Why?
| | Brain Stem | 1 | 1995 | 58 | 0.110 |
Why?
| | Body Weight | 1 | 2016 | 524 | 0.110 |
Why?
| | Mucocele | 1 | 1994 | 5 | 0.110 |
Why?
| | Nasolacrimal Duct | 1 | 1994 | 10 | 0.110 |
Why?
| | Hypercapnia | 1 | 2014 | 16 | 0.110 |
Why?
| | Internet | 1 | 2016 | 265 | 0.110 |
Why?
| | Tuberous Sclerosis | 2 | 2011 | 38 | 0.110 |
Why?
| | Anti-Inflammatory Agents | 2 | 2012 | 164 | 0.110 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2015 | 63 | 0.100 |
Why?
| | Neurofibromatosis 1 | 2 | 1997 | 36 | 0.100 |
Why?
| | Multiple Sclerosis | 1 | 1995 | 77 | 0.100 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2012 | 235 | 0.100 |
Why?
| | Ultrasonography, Doppler, Transcranial | 3 | 2000 | 24 | 0.100 |
Why?
| | Infant, Low Birth Weight | 1 | 2014 | 77 | 0.100 |
Why?
| | Cerebral Infarction | 3 | 1995 | 37 | 0.100 |
Why?
| | Polyradiculoneuropathy | 1 | 1993 | 1 | 0.100 |
Why?
| | Respiratory Insufficiency | 2 | 1994 | 119 | 0.100 |
Why?
| | Infant, Premature, Diseases | 1 | 2014 | 97 | 0.100 |
Why?
| | Choristoma | 1 | 1993 | 22 | 0.100 |
Why?
| | Cerebellar Neoplasms | 1 | 1993 | 24 | 0.100 |
Why?
| | Young Adult | 4 | 2019 | 4511 | 0.100 |
Why?
| | Migraine with Aura | 1 | 2012 | 4 | 0.100 |
Why?
| | Spinal Diseases | 4 | 1998 | 18 | 0.090 |
Why?
| | Meningioma | 1 | 1993 | 48 | 0.090 |
Why?
| | Pharyngeal Diseases | 1 | 1992 | 16 | 0.090 |
Why?
| | Obesity | 2 | 2021 | 1204 | 0.090 |
Why?
| | Head and Neck Neoplasms | 3 | 1994 | 291 | 0.090 |
Why?
| | Eye Neoplasms | 1 | 1992 | 9 | 0.090 |
Why?
| | Pediatrics | 1 | 2015 | 307 | 0.090 |
Why?
| | Task Performance and Analysis | 1 | 2011 | 52 | 0.090 |
Why?
| | Cardiopulmonary Bypass | 1 | 2012 | 91 | 0.090 |
Why?
| | Fever of Unknown Origin | 1 | 1991 | 10 | 0.090 |
Why?
| | Ketamine | 1 | 2012 | 62 | 0.090 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2012 | 46 | 0.090 |
Why?
| | Carotid Artery, Internal, Dissection | 1 | 2011 | 8 | 0.090 |
Why?
| | Subarachnoid Space | 2 | 2024 | 3 | 0.090 |
Why?
| | Cavernous Sinus | 1 | 2011 | 15 | 0.090 |
Why?
| | Respiration, Artificial | 1 | 2014 | 293 | 0.090 |
Why?
| | Heart Diseases | 1 | 2014 | 221 | 0.090 |
Why?
| | Neuroprotective Agents | 1 | 2012 | 101 | 0.090 |
Why?
| | Cerebrovascular Disorders | 3 | 1998 | 51 | 0.090 |
Why?
| | Executive Function | 1 | 2011 | 78 | 0.080 |
Why?
| | Cerebrovascular Circulation | 4 | 2001 | 132 | 0.080 |
Why?
| | Imaging, Three-Dimensional | 1 | 2011 | 145 | 0.080 |
Why?
| | Prenatal Diagnosis | 2 | 2024 | 94 | 0.080 |
Why?
| | Communicable Diseases | 1 | 1991 | 54 | 0.080 |
Why?
| | Anophthalmos | 1 | 1990 | 5 | 0.080 |
Why?
| | Guillain-Barre Syndrome | 1 | 2010 | 13 | 0.080 |
Why?
| | Autoimmune Diseases | 1 | 1991 | 90 | 0.080 |
Why?
| | Neural Tube Defects | 1 | 1990 | 33 | 0.080 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 1990 | 21 | 0.080 |
Why?
| | Cerebral Arteries | 5 | 2000 | 35 | 0.080 |
Why?
| | Visual Acuity | 4 | 2003 | 155 | 0.080 |
Why?
| | Rhabdoid Tumor | 1 | 2009 | 13 | 0.080 |
Why?
| | Neoplasms | 2 | 2018 | 1334 | 0.080 |
Why?
| | Prognosis | 5 | 2013 | 2118 | 0.080 |
Why?
| | Brain Death | 1 | 1989 | 21 | 0.080 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 1989 | 12 | 0.080 |
Why?
| | Syndrome | 3 | 2024 | 248 | 0.080 |
Why?
| | Phenylketonurias | 1 | 1989 | 12 | 0.080 |
Why?
| | Thorax | 1 | 1989 | 15 | 0.070 |
Why?
| | Leucovorin | 1 | 1989 | 19 | 0.070 |
Why?
| | Anemia, Sickle Cell | 3 | 1998 | 105 | 0.070 |
Why?
| | Maxillary Sinus | 1 | 1989 | 3 | 0.070 |
Why?
| | Spinal Canal | 1 | 1989 | 3 | 0.070 |
Why?
| | Ethmoid Sinus | 1 | 1989 | 11 | 0.070 |
Why?
| | Radionuclide Imaging | 6 | 1995 | 107 | 0.070 |
Why?
| | Parenteral Nutrition, Total | 1 | 1989 | 28 | 0.070 |
Why?
| | Neurofibroma | 1 | 1989 | 18 | 0.070 |
Why?
| | Central Nervous System Neoplasms | 1 | 2009 | 69 | 0.070 |
Why?
| | Administration, Rectal | 2 | 2001 | 10 | 0.070 |
Why?
| | Arm | 1 | 1989 | 47 | 0.070 |
Why?
| | Calcinosis | 1 | 1989 | 53 | 0.070 |
Why?
| | Neurologic Examination | 4 | 2012 | 75 | 0.070 |
Why?
| | Receptors, Somatostatin | 1 | 2008 | 3 | 0.070 |
Why?
| | Rhombencephalon | 1 | 2007 | 4 | 0.070 |
Why?
| | Catheterization, Central Venous | 1 | 1989 | 80 | 0.070 |
Why?
| | Mitochondrial Diseases | 1 | 2008 | 45 | 0.070 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 53 | 0.070 |
Why?
| | Injections, Intravenous | 2 | 2012 | 129 | 0.070 |
Why?
| | Inflammation | 1 | 2012 | 652 | 0.070 |
Why?
| | Hematoma, Subdural | 2 | 2023 | 15 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 1990 | 219 | 0.070 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2008 | 250 | 0.070 |
Why?
| | Vascular Resistance | 3 | 2000 | 50 | 0.060 |
Why?
| | Preoperative Care | 2 | 2021 | 173 | 0.060 |
Why?
| | Paranasal Sinuses | 1 | 1986 | 16 | 0.060 |
Why?
| | Injury Severity Score | 2 | 2017 | 166 | 0.060 |
Why?
| | Electroencephalography | 4 | 2015 | 305 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2014 | 5595 | 0.060 |
Why?
| | Optic Chiasm | 3 | 2003 | 8 | 0.060 |
Why?
| | Paraplegia | 1 | 1986 | 8 | 0.060 |
Why?
| | Infant, Premature | 2 | 2014 | 331 | 0.060 |
Why?
| | Aortic Coarctation | 1 | 1986 | 32 | 0.060 |
Why?
| | Connectome | 1 | 2025 | 26 | 0.050 |
Why?
| | Neural Pathways | 1 | 2025 | 91 | 0.050 |
Why?
| | Child Development | 2 | 2020 | 215 | 0.050 |
Why?
| | Neuronal Ceroid-Lipofuscinoses | 1 | 2004 | 6 | 0.050 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2004 | 9 | 0.050 |
Why?
| | Nerve Net | 1 | 2025 | 77 | 0.050 |
Why?
| | Retinal Degeneration | 1 | 2004 | 10 | 0.050 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2008 | 647 | 0.050 |
Why?
| | Gadolinium | 2 | 1995 | 47 | 0.050 |
Why?
| | Exons | 1 | 2004 | 100 | 0.050 |
Why?
| | Molecular Chaperones | 1 | 2004 | 76 | 0.050 |
Why?
| | Optic Atrophy, Hereditary, Leber | 1 | 2003 | 5 | 0.050 |
Why?
| | Retinal Hemorrhage | 1 | 2023 | 15 | 0.050 |
Why?
| | Chromosome Deletion | 1 | 2004 | 138 | 0.050 |
Why?
| | Bone and Bones | 1 | 1987 | 501 | 0.050 |
Why?
| | Carotid Artery, Internal | 2 | 2000 | 22 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 238 | 0.050 |
Why?
| | Dosage Forms | 1 | 2001 | 9 | 0.050 |
Why?
| | Myelin Sheath | 2 | 2018 | 31 | 0.040 |
Why?
| | Blastomycosis | 2 | 1992 | 33 | 0.040 |
Why?
| | Technetium Tc 99m Medronate | 4 | 1992 | 7 | 0.040 |
Why?
| | Haemophilus influenzae | 1 | 2021 | 17 | 0.040 |
Why?
| | Time Factors | 5 | 2013 | 2991 | 0.040 |
Why?
| | Optic Neuritis | 1 | 2001 | 21 | 0.040 |
Why?
| | Orbit | 1 | 2001 | 26 | 0.040 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2021 | 29 | 0.040 |
Why?
| | Pilot Projects | 2 | 2014 | 726 | 0.040 |
Why?
| | Eye Injuries | 1 | 2001 | 27 | 0.040 |
Why?
| | Language | 1 | 2021 | 147 | 0.040 |
Why?
| | Functional Laterality | 2 | 2012 | 92 | 0.040 |
Why?
| | Angiography | 2 | 1998 | 114 | 0.040 |
Why?
| | Biopsy | 3 | 2004 | 600 | 0.040 |
Why?
| | Arthritis, Infectious | 2 | 1992 | 45 | 0.040 |
Why?
| | Cerebral Angiography | 3 | 1995 | 94 | 0.040 |
Why?
| | Diet | 1 | 2023 | 610 | 0.040 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 1993 | 67 | 0.040 |
Why?
| | Arkansas | 2 | 2016 | 2068 | 0.040 |
Why?
| | Neuroblastoma | 2 | 1990 | 55 | 0.040 |
Why?
| | Corpus Callosum | 2 | 1995 | 28 | 0.030 |
Why?
| | Intelligence | 2 | 1995 | 56 | 0.030 |
Why?
| | Hip Joint | 2 | 1989 | 59 | 0.030 |
Why?
| | Age Factors | 3 | 2000 | 1136 | 0.030 |
Why?
| | Fetal Diseases | 1 | 2018 | 54 | 0.030 |
Why?
| | Echoencephalography | 1 | 1997 | 8 | 0.030 |
Why?
| | Fundus Oculi | 2 | 1995 | 26 | 0.030 |
Why?
| | Body Fluids | 1 | 1997 | 20 | 0.030 |
Why?
| | Blood Flow Velocity | 3 | 1998 | 99 | 0.030 |
Why?
| | Postoperative Complications | 3 | 1995 | 1099 | 0.030 |
Why?
| | Reference Values | 3 | 2000 | 311 | 0.030 |
Why?
| | Crohn Disease | 1 | 2018 | 116 | 0.030 |
Why?
| | Attitude to Health | 1 | 2018 | 193 | 0.030 |
Why?
| | Body Burden | 1 | 2016 | 11 | 0.030 |
Why?
| | Ependymoma | 1 | 1996 | 7 | 0.030 |
Why?
| | Ear Neoplasms | 1 | 1996 | 11 | 0.030 |
Why?
| | Hamartoma | 1 | 1996 | 19 | 0.030 |
Why?
| | Electroretinography | 2 | 2008 | 18 | 0.030 |
Why?
| | Retreatment | 1 | 2016 | 60 | 0.030 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2016 | 37 | 0.030 |
Why?
| | Neuroma, Acoustic | 1 | 1996 | 22 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2018 | 392 | 0.030 |
Why?
| | Demography | 1 | 2016 | 91 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 623 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 243 | 0.030 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 1995 | 9 | 0.030 |
Why?
| | Patient Transfer | 1 | 2016 | 99 | 0.030 |
Why?
| | Acetazolamide | 1 | 1995 | 16 | 0.030 |
Why?
| | Diuretics | 1 | 1995 | 27 | 0.030 |
Why?
| | Endoscopy | 1 | 1996 | 128 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2008 | 452 | 0.030 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 1995 | 26 | 0.030 |
Why?
| | Evoked Potentials, Visual | 1 | 1995 | 29 | 0.030 |
Why?
| | DNA, Mitochondrial | 2 | 2008 | 116 | 0.030 |
Why?
| | Sleep Stages | 1 | 1995 | 42 | 0.030 |
Why?
| | Craniopharyngioma | 1 | 1995 | 11 | 0.030 |
Why?
| | Ataxia | 1 | 1995 | 20 | 0.030 |
Why?
| | Oxygen Inhalation Therapy | 1 | 1995 | 21 | 0.030 |
Why?
| | Atrophy | 1 | 1995 | 48 | 0.030 |
Why?
| | Image Enhancement | 1 | 1995 | 49 | 0.030 |
Why?
| | Aneurysm | 1 | 1995 | 32 | 0.030 |
Why?
| | Nausea | 1 | 1995 | 43 | 0.030 |
Why?
| | Carotid Artery Diseases | 1 | 1995 | 33 | 0.030 |
Why?
| | Pituitary Neoplasms | 1 | 1995 | 29 | 0.030 |
Why?
| | Evoked Potentials, Auditory | 1 | 1995 | 90 | 0.030 |
Why?
| | Head | 1 | 1995 | 72 | 0.030 |
Why?
| | Vomiting | 1 | 1995 | 71 | 0.030 |
Why?
| | Lacrimal Apparatus Diseases | 1 | 1994 | 6 | 0.030 |
Why?
| | Cohort Studies | 1 | 2018 | 1557 | 0.030 |
Why?
| | Diarrhea | 1 | 1995 | 96 | 0.030 |
Why?
| | Edema | 1 | 1995 | 64 | 0.030 |
Why?
| | Nasal Obstruction | 1 | 1994 | 12 | 0.030 |
Why?
| | Oximetry | 1 | 1995 | 65 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2014 | 24 | 0.030 |
Why?
| | Mycobacterium chelonae | 1 | 1993 | 7 | 0.030 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2014 | 29 | 0.030 |
Why?
| | Administration, Oral | 1 | 1995 | 456 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 1995 | 345 | 0.030 |
Why?
| | Albinism, Oculocutaneous | 1 | 1993 | 3 | 0.030 |
Why?
| | Birth Injuries | 1 | 1993 | 9 | 0.030 |
Why?
| | Meningocele | 1 | 1993 | 8 | 0.030 |
Why?
| | Brachial Plexus | 1 | 1993 | 11 | 0.030 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 1993 | 19 | 0.030 |
Why?
| | Ophthalmoscopy | 1 | 2013 | 17 | 0.030 |
Why?
| | Cauda Equina | 1 | 1993 | 3 | 0.030 |
Why?
| | Septum Pellucidum | 1 | 1993 | 5 | 0.030 |
Why?
| | Prednisone | 1 | 1993 | 101 | 0.030 |
Why?
| | Spina Bifida Cystica | 1 | 1993 | 1 | 0.030 |
Why?
| | Double-Blind Method | 2 | 2012 | 729 | 0.020 |
Why?
| | Verapamil | 1 | 2012 | 19 | 0.020 |
Why?
| | Delivery, Obstetric | 1 | 1993 | 109 | 0.020 |
Why?
| | Methylprednisolone | 1 | 2012 | 41 | 0.020 |
Why?
| | Calcium Channels | 1 | 2012 | 38 | 0.020 |
Why?
| | Carotid Artery, Common | 1 | 1992 | 45 | 0.020 |
Why?
| | Heterocyclic Compounds | 1 | 1992 | 30 | 0.020 |
Why?
| | Intention to Treat Analysis | 1 | 2012 | 30 | 0.020 |
Why?
| | Patient Discharge | 1 | 1995 | 325 | 0.020 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2012 | 59 | 0.020 |
Why?
| | Calcium Channel Blockers | 1 | 2012 | 57 | 0.020 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2012 | 50 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 1992 | 42 | 0.020 |
Why?
| | Leg Injuries | 1 | 1992 | 11 | 0.020 |
Why?
| | Movement Disorders | 1 | 1992 | 17 | 0.020 |
Why?
| | Otitis Media, Suppurative | 1 | 1992 | 8 | 0.020 |
Why?
| | Blastomyces | 1 | 1992 | 17 | 0.020 |
Why?
| | Gait Disorders, Neurologic | 1 | 2012 | 38 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 1368 | 0.020 |
Why?
| | Central Nervous System | 1 | 2012 | 76 | 0.020 |
Why?
| | Nasopharyngeal Diseases | 1 | 1991 | 3 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 370 | 0.020 |
Why?
| | Reference Standards | 1 | 2011 | 52 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 287 | 0.020 |
Why?
| | Rhabdomyoma | 1 | 1991 | 3 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2012 | 152 | 0.020 |
Why?
| | Temporal Bone | 1 | 1991 | 40 | 0.020 |
Why?
| | Contrast Media | 1 | 1992 | 178 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2012 | 199 | 0.020 |
Why?
| | Bone Diseases | 2 | 1991 | 94 | 0.020 |
Why?
| | Heart Neoplasms | 1 | 1991 | 31 | 0.020 |
Why?
| | Goldenhar Syndrome | 1 | 1990 | 3 | 0.020 |
Why?
| | Neurilemmoma | 1 | 1990 | 25 | 0.020 |
Why?
| | Spina Bifida Occulta | 1 | 1990 | 3 | 0.020 |
Why?
| | Muscular Diseases | 1 | 1991 | 64 | 0.020 |
Why?
| | Tenosynovitis | 1 | 1990 | 5 | 0.020 |
Why?
| | Ankle Joint | 1 | 1990 | 22 | 0.020 |
Why?
| | Tendons | 1 | 1990 | 26 | 0.020 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2009 | 38 | 0.020 |
Why?
| | Prevalence | 1 | 2013 | 1034 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2013 | 331 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2013 | 1049 | 0.020 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 1992 | 305 | 0.020 |
Why?
| | Radiography | 5 | 1989 | 476 | 0.020 |
Why?
| | Mediastinal Diseases | 1 | 1989 | 8 | 0.020 |
Why?
| | DNA | 1 | 2012 | 535 | 0.020 |
Why?
| | Pleural Diseases | 1 | 1989 | 12 | 0.020 |
Why?
| | Legg-Calve-Perthes Disease | 1 | 1989 | 2 | 0.020 |
Why?
| | Intracranial Pressure | 1 | 1989 | 30 | 0.020 |
Why?
| | Cytokines | 1 | 2012 | 627 | 0.020 |
Why?
| | Predictive Value of Tests | 2 | 2008 | 934 | 0.020 |
Why?
| | Hip | 1 | 1989 | 24 | 0.020 |
Why?
| | Synovitis | 1 | 1989 | 21 | 0.020 |
Why?
| | Intussusception | 1 | 1989 | 10 | 0.020 |
Why?
| | Colonic Diseases | 1 | 1989 | 14 | 0.020 |
Why?
| | Femur Head Necrosis | 1 | 1989 | 18 | 0.020 |
Why?
| | Nystagmus, Pathologic | 1 | 2008 | 3 | 0.020 |
Why?
| | Sinusitis | 1 | 1989 | 43 | 0.020 |
Why?
| | GTP Phosphohydrolases | 1 | 2008 | 29 | 0.020 |
Why?
| | Lung Diseases | 1 | 1989 | 84 | 0.020 |
Why?
| | Indium Radioisotopes | 1 | 2008 | 2 | 0.020 |
Why?
| | Somatostatin | 1 | 2008 | 27 | 0.020 |
Why?
| | Vision Disorders | 1 | 2008 | 61 | 0.020 |
Why?
| | Cranial Irradiation | 1 | 2008 | 25 | 0.020 |
Why?
| | Purpura, Thrombotic Thrombocytopenic | 1 | 1987 | 16 | 0.020 |
Why?
| | Bronchial Diseases | 1 | 1987 | 7 | 0.020 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 1988 | 34 | 0.020 |
Why?
| | Tracheal Stenosis | 1 | 1987 | 14 | 0.020 |
Why?
| | Seizures | 1 | 1989 | 203 | 0.020 |
Why?
| | Cellulitis | 1 | 1987 | 11 | 0.020 |
Why?
| | Thrombophlebitis | 1 | 1987 | 19 | 0.020 |
Why?
| | Granulomatous Disease, Chronic | 1 | 1987 | 5 | 0.020 |
Why?
| | Lymphangioma | 1 | 1987 | 9 | 0.020 |
Why?
| | Extremities | 1 | 1987 | 36 | 0.020 |
Why?
| | Cystitis | 1 | 1987 | 18 | 0.020 |
Why?
| | Lymphatic Diseases | 1 | 1987 | 23 | 0.020 |
Why?
| | Spleen | 1 | 1987 | 166 | 0.020 |
Why?
| | Radiation Injuries | 1 | 2008 | 114 | 0.020 |
Why?
| | Granuloma | 1 | 1987 | 46 | 0.020 |
Why?
| | Fibroma | 1 | 1987 | 41 | 0.020 |
Why?
| | Liver Neoplasms | 1 | 1990 | 346 | 0.020 |
Why?
| | Wound Healing | 1 | 1988 | 226 | 0.020 |
Why?
| | Asphyxia Neonatorum | 2 | 2000 | 11 | 0.020 |
Why?
| | Pain | 1 | 1988 | 351 | 0.010 |
Why?
| | Proteins | 1 | 2008 | 351 | 0.010 |
Why?
| | United States | 1 | 2016 | 5409 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2008 | 1212 | 0.010 |
Why?
| | Observer Variation | 2 | 1998 | 138 | 0.010 |
Why?
| | Eye Movements | 2 | 1997 | 23 | 0.010 |
Why?
| | Risk Factors | 1 | 2013 | 4017 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2004 | 63 | 0.010 |
Why?
| | Ependyma | 1 | 1983 | 3 | 0.010 |
Why?
| | Rubella | 1 | 1983 | 3 | 0.010 |
Why?
| | Caudate Nucleus | 1 | 1983 | 14 | 0.010 |
Why?
| | Hypertrophy | 1 | 2003 | 53 | 0.010 |
Why?
| | Birth Weight | 1 | 1983 | 119 | 0.010 |
Why?
| | Cytomegalovirus Infections | 1 | 1983 | 49 | 0.010 |
Why?
| | Alleles | 1 | 2004 | 277 | 0.010 |
Why?
| | Kidney | 1 | 1987 | 715 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2003 | 179 | 0.010 |
Why?
| | Hemorrhage | 1 | 1984 | 226 | 0.010 |
Why?
| | Pelvic Neoplasms | 1 | 1981 | 14 | 0.010 |
Why?
| | Liver | 1 | 1987 | 1150 | 0.010 |
Why?
| | Anterior Cerebral Artery | 1 | 2000 | 3 | 0.010 |
Why?
| | Skin | 1 | 2004 | 419 | 0.010 |
Why?
| | Ultrasonography, Doppler | 1 | 2000 | 42 | 0.010 |
Why?
| | Middle Cerebral Artery | 1 | 2000 | 34 | 0.010 |
Why?
| | Tomography, X-Ray | 1 | 1980 | 2 | 0.010 |
Why?
| | Cholecystography | 1 | 1980 | 2 | 0.010 |
Why?
| | Cholecystitis | 1 | 1980 | 12 | 0.010 |
Why?
| | Tibia | 2 | 1991 | 118 | 0.010 |
Why?
| | Middle Aged | 3 | 2008 | 13419 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 1984 | 645 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2004 | 815 | 0.010 |
Why?
| | Remission, Spontaneous | 1 | 1997 | 25 | 0.010 |
Why?
| | Head Injuries, Closed | 1 | 1995 | 7 | 0.010 |
Why?
| | Migraine Disorders | 1 | 1995 | 46 | 0.010 |
Why?
| | Dogs | 2 | 1989 | 186 | 0.010 |
Why?
| | Encephalitis | 1 | 1994 | 40 | 0.010 |
Why?
| | Basilar Artery | 1 | 1993 | 6 | 0.010 |
Why?
| | Paralysis | 1 | 1993 | 9 | 0.010 |
Why?
| | Vertebral Artery | 1 | 1993 | 11 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1993 | 101 | 0.010 |
Why?
| | Intelligence Tests | 1 | 1993 | 39 | 0.010 |
Why?
| | Verbal Behavior | 1 | 1993 | 36 | 0.010 |
Why?
| | Achievement | 1 | 1993 | 38 | 0.010 |
Why?
| | Arterial Occlusive Diseases | 1 | 1993 | 85 | 0.010 |
Why?
| | Ligation | 1 | 1992 | 63 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1992 | 77 | 0.010 |
Why?
| | Vascular Patency | 1 | 1992 | 88 | 0.010 |
Why?
| | Dermatomycoses | 1 | 1992 | 17 | 0.010 |
Why?
| | Spine | 1 | 1992 | 87 | 0.010 |
Why?
| | Radiographic Image Enhancement | 1 | 1991 | 29 | 0.010 |
Why?
| | Retroperitoneal Space | 1 | 1991 | 26 | 0.010 |
Why?
| | Ulna | 1 | 1991 | 13 | 0.010 |
Why?
| | Discitis | 1 | 1991 | 11 | 0.010 |
Why?
| | Humerus | 1 | 1991 | 17 | 0.010 |
Why?
| | Exophthalmos | 1 | 1990 | 9 | 0.010 |
Why?
| | Oculomotor Muscles | 1 | 1990 | 21 | 0.010 |
Why?
| | Drainage | 1 | 1991 | 92 | 0.010 |
Why?
| | Femur | 1 | 1991 | 133 | 0.010 |
Why?
| | Reoperation | 1 | 1992 | 476 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 1992 | 466 | 0.000 |
Why?
| | Recurrence | 1 | 1991 | 694 | 0.000 |
Why?
| | Ultrasonics | 1 | 1989 | 26 | 0.000 |
Why?
| | Enema | 1 | 1989 | 10 | 0.000 |
Why?
| | Barium Sulfate | 1 | 1989 | 12 | 0.000 |
Why?
| | Rectal Diseases | 1 | 1989 | 12 | 0.000 |
Why?
| | Air | 1 | 1989 | 22 | 0.000 |
Why?
| | Ductus Arteriosus, Patent | 1 | 1989 | 40 | 0.000 |
Why?
| | Ileum | 1 | 1989 | 88 | 0.000 |
Why?
| | Exudates and Transudates | 1 | 1988 | 5 | 0.000 |
Why?
| | Sclerosis | 1 | 1988 | 5 | 0.000 |
Why?
| | Technetium Tc 99m Aggregated Albumin | 1 | 1987 | 4 | 0.000 |
Why?
| | Joint Diseases | 1 | 1988 | 40 | 0.000 |
Why?
| | Clinical Protocols | 1 | 1988 | 109 | 0.000 |
Why?
| | Dilatation | 1 | 1987 | 28 | 0.000 |
Why?
| | Constriction, Pathologic | 1 | 1987 | 91 | 0.000 |
Why?
| | Animals | 2 | 1989 | 13526 | 0.000 |
Why?
| | Gallbladder | 1 | 1980 | 24 | 0.000 |
Why?
| | Acute Disease | 1 | 1980 | 393 | 0.000 |
Why?
| | Aged | 1 | 1980 | 10429 | 0.000 |
Why?
|
|
Glasier's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|